Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2001 • 6,133 citations

An algorithm for the grading of activity in chronic hepatitis C

1996 • 3,858 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

1998 • 3,550 citations

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 • 2,374 citations

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

1998 • 2,112 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 • 1,318 citations

Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

2000 • 739 citations

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

1996 • 675 citations

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1997 • 337 citations

Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C

2000 • 294 citations

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a

2001 • 276 citations

Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

1997 • 259 citations

Clinical Pharmacokinetics of Interferons

1990 • 245 citations

Effect of interferon alfa on the dynamics of hepatitis C virus turnoverin vivo

1996 • 230 citations

Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.

1994 • 193 citations

Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to Interferon

2001 • 163 citations

Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients

1994 • 150 citations

Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials

2001 • 112 citations

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

2001 • 79 citations

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

1998 • 79 citations

A Randomized 4–Arm Multicenter Study of Interferon Alfa-2B Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C Not Responding to Interferon Alone

2001 • 55 citations

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype

2000 • 53 citations

Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chonic HCV infection?

1998 • 39 citations

Efficacy and tolerance of a 6‐month treatment course of daily interferon‐α2a for chronic hepatitis C with cirrhosis

1997 • 27 citations

Comparison of thrice weekly vs daily human leucocyte interferon‐α therapy for chronic hepatitis C

1999 • 10 citations